Congenital defect/syndrome risk assessment interpretive software - India CDSCO Medical Device Registration

Product Information

B·R·A·H·M·S Fast Screen pre-I plus is a software for non-invasive risk assessment of foetal trisomy 21, 18 and 13 in the 1st, of trisomy 21, 18 and foetal neural tube defect in the 2nd trimester of pregnancy as well as for 1st trimester risk assessment for developing pre-eclampsia (B.RA.H.M.S Fast Screen pre-I plus). By using B·R·A·H·M·S Fast Screen pre-I plus 3.0 or 3.1, an individual risk regarding the foetal trisomy 21, 18 and 13 is calculated in pregnant women from parameters such as maternal characteristics, sonographic measurements and biochemical determination of maternal serum markers, measured on B·R·A·H·M·S KRYPTOR systems. The result of the risk calculation serves as a basis for considering further diagnostic measures; it is not conclusive for the presence of a trisomy 21, 18 and 13 in the foetus. The value of maternal AFP in the 2nd trimester of pregnancy can also indicate a fatal neural tube defect requiring further non-invasive and/or invasive examinations for diagnosis. The individual risk of pregnant women for developing pre-eclampsia is calculated based on parameters such as maternal characteristics, sonographic measurements, physiological markers and biochemical determination of maternal serum markers, measured on B·R·A·H·M·S KRYPTOR systems.